Literature DB >> 8223771

Cholescintigraphy in the diagnosis and assessment of benign papillary stenosis.

B Persson1, B Axelsson, H Jacobsson.   

Abstract

Benign papillary stenosis (BPS) is an uncommon condition, the diagnosis of which is often difficult. In this report cholescintigraphy with technetium-99m diethyl-acetanilido-iminodiacetic acid has been evaluated for the diagnosis of BPS, as well as for assessing the effect of treatment by endoscopic sphincterotomy (ES). In 12 patients with BPS, cholescintigraphy was performed before and after ES and the findings compared with those in ten controls. Time-activity curves from regions over the liver and bowel were generated. A significant difference was found in respect of the time for maximum activity (Tmax) over the liver before and after ES. The time for occurrence of bowel activity (Texcr) also showed significant differences before and after ES. Considering both Tmax and Texcr mean values plus two standard deviations in the control group, all BPS patients would have been detected and there would have been no false-positives among the controls. It is concluded that cholescintigraphy should be used in the diagnosis of BPS. The method has high sensitivity and should be applied as an early diagnostic procedure to exclude BPS in patients with clinical suspicion of the disorder. The method can also be used for assessment of endoscopic treatment (ES).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8223771     DOI: 10.1007/bf00180907

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  20 in total

1.  Clinical and scintigraphic assessment of the role of endoscopic sphincterotomy in the treatment of sphincter of Oddi dysfunction.

Authors:  G M Fullarton; T Hilditch; A Campbell; W R Murray
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

Review 2.  Papillary stenosis.

Authors:  M Guelrud
Journal:  Endoscopy       Date:  1988-08       Impact factor: 10.093

Review 3.  The human sphincter of Oddi. Physiology and pathophysiology.

Authors:  J S Goff
Journal:  Arch Intern Med       Date:  1988-12

Review 4.  Pharmacokinetics and clinical application of technetium 99m-labeled hepatobiliary agents.

Authors:  G T Krishnamurthy; F E Turner
Journal:  Semin Nucl Med       Date:  1990-04       Impact factor: 4.446

5.  Assessment of bile flow by radioscintigraphy in patients with biliary-type pain after cholecystectomy.

Authors:  I C Roberts-Thomson; J Toouli; W Blanchett; M Lichtenstein; J T Andrews
Journal:  Aust N Z J Med       Date:  1986-12

6.  [Validity of hepato-biliary functional scintigraphy using 99mTc-diethyl-IDA (author's transl)].

Authors:  J Tongendorff; E Raithel; U Büll; J Grunst; F Trumm; R Scherer
Journal:  Nuklearmedizin       Date:  1978-03       Impact factor: 1.379

7.  Cholescintigraphic detection of functional obstruction of the sphincter of Oddi. Effect of papillotomy.

Authors:  E A Shaffer; N B Hershfield; K Logan; R Kloiber
Journal:  Gastroenterology       Date:  1986-03       Impact factor: 22.682

8.  Endoscopic sphincterotomy for suspected dysfunction of the sphincter of Oddi.

Authors:  B S Thatcher; M V Sivak; F J Tedesco; J A Vennes; S W Hutton; E A Achkar
Journal:  Gastrointest Endosc       Date:  1987-04       Impact factor: 9.427

9.  [Hepatobiliary scintigraphy with (99m)Tc-diethyl-IDA (author's transl)].

Authors:  H J Biersack; M Thelen; R Knopp; H P Breuel; C Winkler
Journal:  Rofo       Date:  1977-11

10.  Sphincter of Oddi dysfunction: results of treatment by endoscopic sphincterotomy.

Authors:  J P Neoptolemos; I S Bailey; D L Carr-Locke
Journal:  Br J Surg       Date:  1988-05       Impact factor: 6.939

View more
  2 in total

1.  Transduodenal sphincteroplasty and transampullary septectomy for sphincter of Oddi dysfunction.

Authors:  George Tzovaras; Brian J Rowlands
Journal:  Ann R Coll Surg Engl       Date:  2002-01       Impact factor: 1.891

2.  Biliary sphincter of Oddi dysfunction type I versus occult biliary microlithiasis in post-cholecystectomy patients: are they both part of the same clinical entity?

Authors:  Farshad Elmi; William B Silverman
Journal:  Dig Dis Sci       Date:  2009-04-01       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.